Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome

Abstract Mesenchymal stem cells (MSCs) are a promising form of therapy for acute respiratory distress syndrome (ARDS). The objective of this study was twofold: (a) to characterize cytokine expression in serum from ARDS subjects receiving MSCs and (b) to determine MSC function following “precondition...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Amy L. Xu, Luis A. Rodriguez II, Kerfoot P. Walker III, Arezoo Mohammadipoor, Robin M. Kamucheka, Leopoldo C. Cancio, Andriy I. Batchinsky, Ben Antebi
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2019
Materias:	Mesenchymal stem cells Acute respiratory distress syndrome Preconditioning Inflammatory mediators Inhalation injury Medicine (General) R5-920 Cytology QH573-671
Acceso en línea:	https://doaj.org/article/b344c35130f34df4ad1208665fff0114
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome

Ejemplares similares